Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > MORE DILUTION COMING! it will take another 1 year
View:
Post by matt1791 on Feb 02, 2016 2:24pm

MORE DILUTION COMING! it will take another 1 year

SO IT WILL TAKE ANOTHER 1 YEAR TO GET THE RESULT OF NEW TRIAL.. THEY WILL NEED MORE MONEY..  DILUTION IS ON THE WAY..
Comment by bailmeout on Feb 02, 2016 2:27pm
how about 5 yrs
Comment by stockman6767 on Feb 02, 2016 2:28pm
Yup. dilution will come - but not at today's SP. They are OK for cash for several months and by then TST will be back in the twenties or thirties and the dilution will be much less than today and not too terrible.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities